318 related articles for article (PubMed ID: 26189878)
1. Human leukocyte antigens and genetic susceptibility to lymphoma.
McAulay KA; Jarrett RF
Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
[TBL] [Abstract][Full Text] [Related]
2. Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.
Johnson PC; McAulay KA; Montgomery D; Lake A; Shield L; Gallagher A; Little AM; Shah A; Marsh SG; Taylor GM; Jarrett RF
Int J Cancer; 2015 Sep; 137(5):1066-75. PubMed ID: 25648508
[TBL] [Abstract][Full Text] [Related]
3. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
[TBL] [Abstract][Full Text] [Related]
4. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.
Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K
Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052
[TBL] [Abstract][Full Text] [Related]
5. HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02.
Martín P; Krsnik I; Navarro B; Provencio M; García JF; Bellas C; Vilches C; Gomez-Lozano N
PLoS One; 2015; 10(8):e0135512. PubMed ID: 26261988
[TBL] [Abstract][Full Text] [Related]
6. HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.
Fletcher LB; Veenstra RN; Loo EY; Hwang AE; Siddiqi IN; Visser L; Hepkema BG; Nolte IM; van den Berg A; Cozen W; Diepstra A
PLoS One; 2017; 12(3):e0174457. PubMed ID: 28334025
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings.
Kamper PM; Kjeldsen E; Clausen N; Bendix K; Hamilton-Dutoit S; d'Amore F
Br J Haematol; 2005 Jun; 129(5):615-7. PubMed ID: 15916683
[TBL] [Abstract][Full Text] [Related]
8. HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma.
Niens M; Jarrett RF; Hepkema B; Nolte IM; Diepstra A; Platteel M; Kouprie N; Delury CP; Gallagher A; Visser L; Poppema S; te Meerman GJ; van den Berg A
Blood; 2007 Nov; 110(9):3310-5. PubMed ID: 17630352
[TBL] [Abstract][Full Text] [Related]
9. Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups.
Huang X; Kushekhar K; Nolte I; Kooistra W; Visser L; Bouwman I; Kouprie N; Veenstra R; van Imhoff G; Olver B; Houlston RS; Poppema S; Diepstra A; Hepkema B; van den Berg A
Blood; 2011 Nov; 118(19):5211-7. PubMed ID: 21921049
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region.
Diepstra A; Niens M; te Meerman GJ; Poppema S; van den Berg A
Eur J Haematol Suppl; 2005 Jul; (66):34-41. PubMed ID: 16007866
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.
Wang SS; Abdou AM; Morton LM; Thomas R; Cerhan JR; Gao X; Cozen W; Rothman N; Davis S; Severson RK; Bernstein L; Hartge P; Carrington M
Blood; 2010 Jun; 115(23):4820-3. PubMed ID: 20385791
[TBL] [Abstract][Full Text] [Related]
12. On the aetiology of Hodgkin lymphoma.
Hjalgrim H
Dan Med J; 2012 Jul; 59(7):B4485. PubMed ID: 22759852
[TBL] [Abstract][Full Text] [Related]
13. HLA class I associations with EBV+ post-transplant lymphoproliferative disorder.
Jones K; Wockner L; Thornton A; Gottlieb D; Ritchie DS; Seymour JF; Kumarasinghe G; Gandhi MK
Transpl Immunol; 2015 Mar; 32(2):126-30. PubMed ID: 25731678
[TBL] [Abstract][Full Text] [Related]
14. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
Rubicz R; Yolken R; Drigalenko E; Carless MA; Dyer TD; Bauman L; Melton PE; Kent JW; Harley JB; Curran JE; Johnson MP; Cole SA; Almasy L; Moses EK; Dhurandhar NV; Kraig E; Blangero J; Leach CT; Göring HH
PLoS Genet; 2013; 9(1):e1003147. PubMed ID: 23326239
[TBL] [Abstract][Full Text] [Related]
15. HLA class II polymorphism in Egyptian children with lymphomas.
Al-Tonbary Y; Abdel-Razek N; Zaghloul H; Metwaly S; El-Deek B; El-Shawaf R
Hematology; 2004 Apr; 9(2):139-45. PubMed ID: 15203870
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies.
Teras LR; Rollison DE; Pawlita M; Michel A; Brozy J; de Sanjose S; Blase JL; Gapstur SM
Int J Cancer; 2015 Jan; 136(1):108-16. PubMed ID: 24831943
[TBL] [Abstract][Full Text] [Related]
17. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
18. The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.
Niens M; van den Berg A; Diepstra A; Nolte IM; van der Steege G; Gallagher A; Taylor GM; Jarrett RF; Poppema S; te Meerman GJ
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2280-4. PubMed ID: 17119058
[TBL] [Abstract][Full Text] [Related]
19. SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression.
Ten LC; Chin YM; Tai MC; Chin EF; Lim YY; Suthandiram S; Chang KM; Ong TC; Bee PC; Mohamed Z; Gan GG; Ng CC
Sci Rep; 2017 Jan; 7():41400. PubMed ID: 28139690
[TBL] [Abstract][Full Text] [Related]
20. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.
Hjalgrim H; Rostgaard K; Johnson PC; Lake A; Shield L; Little AM; Ekstrom-Smedby K; Adami HO; Glimelius B; Hamilton-Dutoit S; Kane E; Taylor GM; McConnachie A; Ryder LP; Sundstrom C; Andersen PS; Chang ET; Alexander FE; Melbye M; Jarrett RF
Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6400-5. PubMed ID: 20308568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
